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Abstract




Patient(s)—A total of 886,686 fresh, nondonor cycles reported to the National Assisted 
Reproductive Technology Surveillance System during 1999–2010, of which 17,166 met criteria 
for elective single ET.
Intervention(s)—None.
Main Outcome Measure(s)—Rates of elective single ET and good perinatal outcome (term, 
singleton infant with normal birth weight).
Result(s)—In 2010, elective single ET comprised 5.6% of all fresh transfers, representing an 
eightfold increase since publication of first guidelines in 2004 recommending elective single ET. 
Compared with other ETs, elective single ETs were nearly twice as likely to result in a good 
perinatal outcome (37.1% vs. 18.9%, respectively). Among women using elective single ET, those 
aged <35 and 35–37 years had a good perinatal outcome (40.2% and 32.5%, respectively). In 
multivariable, log-binomial analyses, factors positively associated with a good perinatal outcome 
included male factor infertility, day 5 ET, and having ≥3 supernumerary embryos for 
cryopreservation.
Conclusion(s)—Between 1999 and 2010, national rates of elective single ET increased. Given 
the frequency of good perinatal outcomes among women aged 35–37 years, guidelines for elective 
single ET could be expanded to include patients in this age group with favorable prognoses.
Reprint requests: Marissa L. Steinberg, B.A., Centers for Disease Control and Prevention, 4770 Buford Highway NE, MS K-34, 
Atlanta, Georgia 30341 (MLStei2@emory.edu).. 
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Multiple gestations, and their associated complications, remain the most common adverse 
outcome associated with assisted reproductive technology (ART). The most effective 
method for reducing the risk of multiple births after ART is to limit the number of embryos 
transferred. Evolving practice guidelines from the American Society for Reproductive 
Medicine (ASRM) and the Society of Assisted Reproductive Technologies (SART) have led 
to a steady decline in the frequency of higher order (≥3) ETs during the past decade (1). This 
downward trend has caused an increased number of double ETs, resulting in an unchanged, 
or even slightly increased, rate of twin gestation resulting from ART (1). Elective single ET, 
defined as the transfer of only one embryo when more than one high-quality embryo is 
available, has been proposed as the only means of avoiding multiple gestations after IVF (2).
As observed in several studies (3–9), elective single ET successfully reduces the risk of 
multiple gestations, without significantly compromising live birth rates. However, in prior 
studies, the population had been restricted to select subsets of patients with the most 
“favorable prognosis,” thereby limiting the generalizability of the findings (3–9). In a study 
of unselected patients (10), use of elective single ET effectively eliminated multiple 
gestations, but nearly halved pregnancy rates (PRs), compared with double ETs. Due to low 
rates of elective single ET in the United States, there has only been one small, single center 
analysis evaluating factors associated with birth outcomes after fresh elective single ET (11). 
An analysis of national data would add to this study, which found that younger maternal age 
and blastocyst expansion were positively associated with clinical pregnancy and live birth 
among patients with favorable prognosis.
Given the limited information on use of elective single ET in the United States, we analyzed 
data from the Centers for Disease Control and Prevention National ART Surveillance 
System (NASS) to estimate national trends in elective single ET from 1999 through 2010. 
Furthermore, because the motivation behind promoting elective single ET is to increase the 
rate of healthy, singleton infants after ART, we sought to identify characteristics associated 
with a good perinatal outcome after elective single ET.
MATERIALS AND METHODS
The data used for this analysis were obtained from NASS, which was established after the 
enactment of the Fertility Clinic Success Rate and Certification Act of 1992. This law 
mandates that ART clinics report data annually to the Centers for Disease Control and 
Prevention for all cycles initiated during that year (12). The data include patient 
demographics, medical and obstetric history, infertility diagnosis, and information regarding 
resultant pregnancies and births. Approximately 6.5% of ART clinics did not provide data to 
Centers for Disease Control and Prevention in 2010 (13). Because most nonreporting clinics 
are small, we estimate that NASS contains information on more than 97% of all ART cycles 
performed in the United States (13). The study was reviewed and approved by the 
Institutional Review Board of the Centers for Disease Control and Prevention.
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The elective single ET study population was defined as fresh, nondonor cycles in which a 
single embryo was transferred and at least one supernumerary embryo was available for 
cryopreservation. The comparison group consisted of all other fresh, nondonor cycles. These 
included cycles in which only one embryo was available for transfer (single ET without 
additional embryos available for cryopreservation), as well as transfers of more than one 
embryo.
The characteristics assessed included maternal age, race/ethnicity, infertility diagnosis, 
number of prior pregnancies, number of prior spontaneous abortions, number of prior live 
births, number of prior ART cycles, year of cycle treatment, insurance mandate status for 
state of residence, number of oocytes retrieved, use of intracytoplasmic sperm injection 
(ICSI) (± male factor infertility), use of assisted hatching, use of preimplantation genetic 
diagnosis (for years 2004 and later), embryo stage at transfer, number of embryos 
transferred, and number of supernumerary embryos cryopreserved. Because race/ethnicity 
was unknown or missing in nearly 40% of the study population, an unknown/missing 
category was included to allow evaluation of these data in multivariable analyses. Also, as 
patients may have had more than one infertility diagnosis, these diagnoses were not 
mutually exclusive. To assess potential temporal differences in elective single ET practices, 
we compared transfers performed in 2005–2010 with those performed in 1999–2004, as the 
first ASRM/SART guidelines recommending elective single ET were published in 
September 2004 (14). With regard to embryo stage at transfer, we chose to restrict our 
analysis to the two most common days for embryo transfer (day 3 for cleavage stage and day 
5 for blastocyst stage), which together represented 82.5% of all transfers.
A “good perinatal outcome” was defined as the live birth of a singleton infant born at term 
(≥37 completed weeks of gestation) and at a normal birth weight (≥2,500 g) (15). 
Gestational age was calculated by subtracting the date of oocyte retrieval from the date of 
delivery, then adding 14 days to adjust for the theoretical date of the last menstrual period.
We used SAS statistical software version 9.3 (SAS Institute) to conduct all analyses. For all 
transfers and selected maternal age strata, we calculated the percentage of all ETs meeting 
elective single ET criteria for each year. We used Mantel-Haenszel statistics to assess trends 
in the proportion of elective single ET during the study period, and two-tailed χ2 tests to 
compare the distribution of maternal and cycle characteristics for the elective single ET 
group with all other fresh, nondonor transfers during the study period.
To evaluate factors associated with good perinatal outcome among the cycles with elective 
single ET, we calculated the frequency of good outcomes for each of these maternal and 
cycle characteristics. Log-binomial models were used to calculate unadjusted and adjusted 
risk ratios (RR) for the association between maternal and cycle characteristics and a good 
perinatal outcome after elective single ET. The number of previous pregnancies was not 
included as a predictor in the adjusted models because it represented the sum of number of 
previous abortions and number of previous live births, two variables that were already 
included in the model. Preimplantation genetic diagnosis was also excluded from the models 
because this information was not ascertained for all study years. We also conducted 
stratified analyses to examine potential effect modification by maternal age using a variety 
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of different maternal age groupings; no differential effects were noted thus stratified results 
were not presented. Due to the high proportion of missing or unknown race data, we 
compared the findings for adjusted models with and without the race variable. Because 
differences between the two models were nominal, we retained race in the final model.
RESULTS
During the study years 1999–2010, a total of 1,541,825 ART cycles were included in NASS. 
Of the 1,111,766 cycles using fresh, nondonor oocytes, 886,686 (79.8%) proceeded to 
transfer at least 1 embryo, and 17,166 (1.9%) met elective single ET criteria.
Until 2004, less than 1% of all transfers in the United States were elective single ET (Fig. 1). 
Since that time, there has been an eightfold increase in national elective single ET rates 
(from 0.72% in 2004 to 5.6% in 2010). In 2010, 9.3% of all transfers in women less than 35 
years of age were elective single ET, as were 5.1% of ETs in women aged 35–37 years. 
Since 1999, each age group has shown a significant positive trend in rates of elective single 
ET (all P for trend <.001).
With the exception of number of prior pregnancies, the distribution of all characteristics 
assessed differed significantly between the elective single ET group and all other transfers 
(Table 1). For example, patients undergoing elective single ET were more likely to be 
younger than 35 years, have a diagnosis of ovulatory disorder, and have no history of prior 
ART cycles, when compared to all other transfers. Cycles resulting in elective single ET 
were more likely to have taken place after 2004, have more than 16 oocytes retrieved, and 
have transferred a blastocyst-stage embryo.
More than one-third of elective single ET resulted in a good perinatal outcome (37.1%, 
compared with 18.9% of all other transfers during the same period [data not shown]). 
Approximately 40% of elective single ET in the two youngest age groups (<30 years and 
30–34 years) resulted in a good perinatal outcome, whereas 32.5% of elective single ET in 
the 35- to 37-year-old age group reported the same outcome (Table 2). Among all other 
transfers, approximately 22% and 20% of transfers in women <35 and 35–37 years, 
respectively, resulted in a good perinatal outcome. The findings were similar for women 
with no prior ART cycles (23% and 21%, respectively) (data not shown). Patients 
undergoing ART for the first time also had a higher-than-average rate of good outcomes 
(38.4%). Among cycles where ET occurred on day 5, 39.7% resulted in a good perinatal 
outcome. Similarly, when five or more supernumerary embryos were available for 
cryopreservation 41.0% of cycles resulted in a good perinatal outcome.
In the adjusted model, a primary diagnosis of male factor infertility, a treatment start date of 
2005 or later, and an ET on day 5 were positively associated with a good perinatal outcome 
after elective single ET. The following characteristics were found to be negatively 
associated with a good perinatal outcome: race/ethnicity (specifically, non-Hispanic black, 
Hispanic, or Asian/Pacific Islander); primary infertility diagnosis of uterine factor; use of 
ICSI; and use of assisted hatching.
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The strongest positive association with good perinatal outcome was for the use of day 5 ET, 
compared with day 3 ET (adjusted RR 1.33, confidence interval [CI] 1.24–1.43). 
Conversely, the strongest negative associations were estimated for maternal age of 41 years 
or older, compared with age less than 30 years (adjusted RR 0.36, CI 0.23–0.57), and non-
Hispanic black race, compared with non-Hispanic white race (adjusted RR 0.60, CI 0.50–
0.72).
Among the predictors with ordinal categories, significant linear trends in the risk ratios were 
noted for maternal age, number of prior spontaneous abortions, and number of super-
numerary embryos cryopreserved.
DISCUSSION
Using national data on cycles of fresh, nondonor ETs, we found that rates of elective single 
ET increased significantly across all age groups from 1999–2010, with elective single ET 
comprising 5.6% of ART cycles in 2010. This trend is likely due to continually evolving 
guidelines from ASRM and SART promoting fewer embryos per transfer, as well as 
improvements in embryo culture that have facilitated the selection of higher quality embryos 
for transfer (1, 16). Although we observed an eightfold increase in elective single ET rates 
during the study period, the proportion of elective single ET in the United States remains 
low compared with other developed countries (1). Although the greatest increases in the 
present study were observed among patients less than 35 years of age, for whom ET 
guidelines currently recommend elective single ET, rates of elective single ET among 
patients aged 35–37 years have increased by an average of 0.7% per year since 2004, and 
comprised more than 5% of all transfers in this age group in 2010. This trend suggests that 
clinicians are expanding the current elective single ET guidelines to include a slightly 
broader patient population, although it is unclear what prognostic criteria are being used to 
identify good candidates.
Previous studies investigating prognostic criteria for elective single ET evaluated the 
outcomes of clinical pregnancy or live birth (1, 11, 17–19). We chose to focus on having a 
good perinatal outcome. This measure, a variation of the Birth Emphasizing a Successful 
Singleton at Term outcome, which was first proposed by Min and colleagues (20), attempts 
to redefine “success” after ART as the delivery of a healthy singleton infant. We found that 
elective single ETs were nearly twice as likely to result in a good perinatal outcome 
compared with all other fresh, nondonor ETs. This finding adds to the growing body of 
literature supporting elective single ET as an effective means of avoiding the adverse 
outcomes commonly associated with ART (15, 21).
Within the elective single ET group, good perinatal outcomes were most common among 
women less than 35 years of age or those undergoing their first ART cycle–the women 
considered to be of “a more favorable prognosis” by ASRM/SART guidelines on number of 
embryos transferred (22). However, 32.5% of elective single ET in women aged 35–37 
years resulted in a good perinatal outcome (vs. 40.2% in the under-35-years cohort). These 
findings, like those of Veleva and co-workers (23) suggest that the ET guidelines could 
potentially be expanded to include the age group 35–37 years as candidates for elective 
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single ET. The increasing rates of elective single ET observed in this age group suggest that 
clinicians may already be practicing based on anecdotal evidence supporting this conclusion.
In our analysis, the strongest independent predictor of a good perinatal outcome after 
elective single ET was ET on day 5. This finding builds on a study in which Papanikolaou 
and co-workers (24) found higher rates of pregnancy and delivery among a group of 
favorable prognosis patients undergoing transfer of a single blastocyst-stage embryo, 
compared with those undergoing transfer of a single cleavage-stage embryo. We also found 
having three or more supernumerary embryos available for cryopreservation is associated 
with a good outcome. The survival of one or more embryos in culture until day 5, for 
transfer or cryopreservation, may be an indirect measure of “good embryo quality,” which 
current ET guidelines include as a characteristic associated with a more favorable prognosis 
(22).
We found significant racial/ethnic disparities with respect to good perinatal outcomes after 
elective single ET. Specifically, non-Hispanic black, Hispanic, and Asian/Pacific Islander 
race/ethnicity were less likely to have a good perinatal outcome after elective single ET. 
Although these findings are consistent with other analyses of national ART data (25–29), 
they should be interpreted with caution; in nearly 40% of cycles, data regarding maternal 
race/ethnicity was missing or unknown. A recent systematic review of national race/
ethnicity reporting for ART suggested that it is not possible to draw definitive conclusions 
regarding disparities due to lack of universal reporting of this race/ethnicity (30).
Although the diagnosis of male factor infertility has yet to be reported as a prognostic factor 
for elective single ET, we found it to be a positive predictor of good perinatal outcome. A 
potential explanation for this finding may be that, among couples where male factor is the 
only infertility diagnosis, the female is otherwise healthy and therefore more likely to have a 
good perinatal outcome. Furthermore, we found uterine factor infertility to be inversely 
associated with good perinatal outcome, which is consistent with previous studies that 
demonstrated worsened pregnancy outcomes among patients with uterine factor (11, 15). 
Interestingly, in a previous analysis of national data, Luke and colleagues (31) suggested 
that the diagnosis of uterine factor was more common among women undergoing elective 
single ET; however, our data do not support their conclusion.
Strengths of our study include the use of nationwide surveillance data with nearly universal 
reporting of ART procedures, which allowed for the analysis of the largest population of 
elective single ET in the United States to date. Furthermore, the use of multiple years of 
national data allowed for the first comprehensive analysis of elective single ET trends in the 
United States. Unlike previous studies evaluating prognostic criteria for elective single ET, 
we did not restrict our study population to patients with a favorable prognosis. Given the 
large sample size and increased representativeness of national data, our findings can be 
applied broadly by clinicians to all patients considering ART.
Our findings are subject to several limitations. As indicated in the SART reporting 
guidelines, elective single ET is generally defined as “an embryo transfer in which more 
than one high-quality embryo exists but it was decided to transfer only one embryo.” 
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Because NASS does not collect information on embryo morphology, our definition of 
elective single ET did not include such parameters, and, thus, we were unable to directly 
evaluate whether better embryo quality is associated with a good perinatal outcome after 
elective single ET, particularly among women 35–37 years of age. In addition, we could not 
evaluate the potential impact of clinic policies on elective single ET use. A clinician's 
decision to recommend elective single ET may be affected by the clinic's PRs, an element of 
elective single ET selection criteria that we did not assess. Finally, NASS validation results 
indicate that infertility diagnosis has a relatively high discrepancy rate (approximately 18% 
in 2010) (13), with about half of the discrepancies due to report of a single cause of 
infertility when multiple causes were noted in the medical record.
Although rates of elective single ET increased significantly during the 12-year study period, 
our findings suggest there may be additional patients who could be considered strong 
candidates for elective single ET. Continuing to redefine a “successful” ART outcome as a 
healthy singleton birth, may further motivate clinicians to consider elective single ET for 
their patients. By investigating factors associated with a good perinatal outcome, we aimed 
to help identify those patients who may be good candidates for elective single ET but are not 
included in the “favorable prognosis” group by the current ET guidelines. Our findings 
support better birth outcomes associated with younger age, day 5 transfer, race/ethnicity 
(non-Hispanic white), and the absence of uterine factor infertility. However, our results also 
indicate that the use of elective single ET may be appropriate for women aged 35–37 years, 
and couples affected by male factor infertility. Consideration of these factors may further 
continue the downward trend in number of embryos transferred, thereby decreasing the 
current rate of twin births among patients receiving ART.
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TABLE 1
Characteristics of the fresh, nondonor elective single ET compared with all other fresh, nondonor transfers—
United States, 1999–2010.
Characteristic Elective single ET (%) All others (%)
Total 17,166 (100) 869,520 (100)
Maternal age, y
a
 <30 3,821 (22.2) 108,689 (12.5)
 30–34 8,406 (49.0) 281,923 (32.4)
 35–37 3,599 (21.0) 198,192 (22.8)
 38–40 1,097 (6.4) 172,089 (19.8)
 ≥41 243 (1.4) 108,627 (12.5)
Race/ethnicity
a
 Non-Hispanic white 7,731 (45.0) 392,460 (45.1)
 Non-Hispanic black 600 (3.5) 31,213 (3.6)
 Hispanic 1,454 (8.5) 47,024 (5.4)
 Asian/Pacific Islander 626 (3.7) 38,574 (4.4)
 Other race 28 (0.2) 923 (0.1)
 Unknown or missing 6,727 (39.2) 359,326 (41.3)
Infertility diagnosis
a,b
 Tubal factor 2,950 (17.2) 185,540 (21.3)
 Endometriosis 1,706 (10.0) 123,789 (14.2)
 Uterine factor 1,004 (5.9) 44,193 (5.1)
 Ovulatory disorder 3,717 (21.7) 122,997 (14.2)
 Diminished ovarian reserve 953 (5.6) 142,034 (16.3)
 Male factor 6,143 (35.8) 329,417 (37.9)
 Unexplained 2,620 (15.3) 107,924 (12.4)
No. of prior pregnancies
 0 8,113 (47.4) 409,625 (47.2)
 1 4,547 (26.5) 226,411 (26.1)
 ≥2 4,472 (26.1) 232,140 (26.7)
No. of prior spontaneous abortions
a
 0 12,943 (75.4) 603,721 (69.5)
 1 2,864 (16.7) 169,080 (19.5)
 ≥2 1,356 (7.9) 95,783 (11.0)
No. of prior live births
a
 0 11,156 (65.5) 628,104 (72.6)
 1 4,325 (25.4) 174,947 (20.2)
 ≥2 1,548 (9.1) 61,680 (7.1)
No. of prior ART cycles
a
 0 12,882 (75.0) 486,083 (55.9)
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Characteristic Elective single ET (%) All others (%)
 1 2,068 (12.1) 177,067 (20.4)
 ≥2 2,216 (12.9) 205,832 (23.7)
Year cycle treatment started
a
 1999–2004 (first guidelines September 2004) 1,597 (9.3) 393,050 (45.2)
 2005–2010 15,569 (90.7) 476,470 (54.8)
Insurance mandate status
a
 State not providing coverage for ART 5,830 (36.1) 311,713 (39.0)
 State providing coverage 10,312 (63.9) 487,996 (61.0)
No. of oocytes retrieved
a
 1–10 3,523 (20.5) 406,726 (46.8)
 11–15 4,391 (25.6) 217,602 (25.0)
 ≥16 9,252 (53.9) 245,192 (28.2)
Use of intracytoplasmic sperm injection (ICSI)
a
 Did not use ICSI 5,946 (34.7) 287,588 (33.1)
 Used ICSI 11,201 (65.3) 581,551 (66.9)










Use of assisted hatching
a
 Did not use assisted hatching 14,124 (82.3) 477,975 (55.0)
 Used assisted hatching 3,042 (17.7) 391,545 (45.0)
Use of preimplantation genetic diagnosis (PGD)
a,d
 Did not use PGD 14,491 (91.4) 496,167 (95.4)
 Used PGD 1,356 (8.6) 23,857 (4.6)
 Missing 1,319 349,496
Embryo stage at transfer
a
 Cleavage stage (day 3) 2,667 (22.0) 537,074 (74.6)
 Blastocyst stage (day 5) 9,476 (78.0) 182,554 (25.4)
 Missing/out of range 5,023 149,892
No. of embryos transferred
a
 1 17,166 (100) 70,024 (8.0)
 2 0 364,723 (42.0)
 ≥3 0 434,773 (50.0)
No. of supernumerary embryos cryopreserved
a
 Unknown 0 4,226 (0.5)
 0 0 594,623 (68.4)
 ≥1 17,166 (100) 270,671 (31.1)
Note: ART = assisted reproductive technology.
Steinberg. Elective single ET trends and outcome predictors. Fertil Steril 2013.
a
P<.001 for χ2 test of distribution of variable in the elective single ET group versus all other transfers.
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b
percentages do not sum to 100 because groups are not mutually exclusive (patient may carry multiple diagnoses).
c
Among those using ICSI.
d
Data only available for 2004 and later.
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TABLE 2
Predictors of good perinatal outcome after fresh, nondonor elective single ET—United States, 1999–2010.
% Elective single ET with good 
perinatal outcome
Exposure N %









 <30 1,592 41.7 Reference Reference
 30–34 3,321 39.5 0.95 (0.91–0.99) 0.97 (0.92–1.03)
 35–37 1,169 32.5 0.78 (0.73–0.83) 0.85 (0.79–0.92)
 38–40 251 22.9 0.55 (0.49–0.62) 0.60 (0.52–0.70)
 ≥41 28 11.5 0.28 (0.19–0.39) 0.36 (0.23–0.57)
Race/ethnicity
 Non-Hispanic white 3,127 40.5 Reference Reference
 Non-Hispanic black 157 26.2 0.65 (0.56–0.74) 0.60 (0.50–0.72)
 Hispanic 202 32.2 0.80 (0.71–0.90) 0.80 (0.69–0.92)
 Asian/Pacific Islander 439 30.2 0.75 (0.69–0.81) 0.77 (0.69–0.85)
 Other race 10 35.7 0.88 (0.54–1.45) 1.11 (0.68–1.81)
 Unknown/missing 2,426 36.1 0.89 (0.86–0.93) 0.94 (0.89–0.98)
Infertility diagnosis
 No tubal factor 5,365 37.7 Reference Reference
 Tubal factor 996 33.8 0.89 (0.85–0.95) 0.97 (0.91–1.03)
 No endometriosis 5,752 37.2 Reference Reference
 Endometriosis 609 35.7 0.96 (0.90–1.03) 0.94 (0.86–1.01)
 No uterine factor 6,114 37.8 Reference Reference
 Uterine factor 247 24.6 0.65 (0.58–0.73) 0.64 (0.55–0.73)
 No ovulatory disorder 4,850 36.1 Reference Reference
 Ovulatory disorder 1,511 40.7 1.13 (1.08–1.18) 1.00 (0.94–1.06)
 No diminished ovarian reserve 6,104 37.6 Reference Reference
 Diminished ovarian reserve 257 27.0 0.72 (0.64–0.80) 0.95 (0.83–1.08)
 No male factor 3,961 35.9 Reference Reference
 Male factor 2,400 39.1 1.09 (1.04–1.13) 1.08 (1.02–1.14)
No. of prior spontaneous abortions
b
 0 5,014 38.7 Reference Reference
 1 955 33.3 0.86 (0.81–0.91) 0.90 (0.84–0.96)
 ≥2 392 28.9 0.75 (0.68–0.81) 0.87 (0.79–0.97)
No. of prior live births
 0 4,205 37.7 Reference Reference
 1 1,644 38.0 1.01 (0.96–1.05) 1.11 (1.05–1.17)
 ≥2 468 30.2 0.80 (0.74–0.87) 0.90 (0.81–0.99)
No. of prior ART cycles
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% Elective single ET with good 
perinatal outcome
Exposure N %






 0 4,946 38.4 Reference Reference
 1 706 34.1 0.90 (0.83–0.95) 0.96 (0.89–1.04)
 ≥2 709 32.0 0.83 (0.78–0.89) 0.96 (0.89–1.04)
Year cycle treatment started
 1999–2004 471 29.5 Reference Reference
 2005–2010 5,890 37.8 1.28 (1.19–1.39) 1.23 (1.13–1.34)
Insurance mandate status
 State not providing coverage for ART 2,330 40.0 Reference Reference
 State providing coverage 3,717 36.1 0.90 (0.86–0.94) 0.96 (0.91–1.00)
No. of oocytes retrieved
 1–10 1,083 30.7 Reference Reference
 11–15 1,646 37.5 1.22 (1.15–1.30) 1.05 (0.97–1.13)
 ≥16 3,632 39.3 1.28 (1.21–1.35) 0.99 (0.92–1.07)
Use of intracytoplasmic sperm injection (ICSI)
 Did not use ICSI 2,299 38.7 Reference Reference
 Used ICSI 4,058 36.2 0.94 (0.90–0.98) 0.88 (0.84–0.93)
Use of assisted hatching
 Did not use assisted hatching 5,464 38.7 Reference Reference
 Used assisted hatching 897 29.5 0.76 (0.72–0.81) 0.88 (0.82–0.95)
Embryo stage at transfer
 Cleavage stage (day 3) 767 28.8 Reference Reference
 Blastocyst stage (day 5) 3,765 39.7 1.38 (1.30–1.47) 1.33 (1.24–1.43)
No. of supernumerary embryos cryopreserved
b
 1–2 1,768 31.4 Reference Reference
 3–4 1,750 38.0 1.21 (1.15–1.27) 1.11 (1.04–1.19)
 ≥5 2,843 41.0 1.30 (1.24–1.37) 1.20 (1.12–1.27)
Note: ART = assisted reproductive technology, CI = confidence interval.
Steinberg. Elective single ET trends and outcome predictors. Fertil Steril 2013.
a
Regression model adjusted for all other variables listed in the table.
b
P<.001 for linear trends in risk ratios.
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